| Literature DB >> 34525985 |
Rui Chen1, Li-Zhen Piao1, Ling Liu2, Xiao-Fei Zhang3.
Abstract
BACKGROUND: Asthma is a chronic inflammatory disorder of the airways involving many different factors. This study aimed to screen for the critical genes using DNA methylation/CpGs and miRNAs involved in childhood atopic asthma.Entities:
Keywords: Atopic asthma; DNA methylation profile; Gene expression profile; miRNA
Mesh:
Substances:
Year: 2021 PMID: 34525985 PMCID: PMC8444351 DOI: 10.1186/s12890-021-01655-8
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.317
Fig. 1Volcano plot for the differentially expressed genes (a) and DNA methylation data (b). The horizontal dotted line represents an FDR = 0.05 threshold line;the red vertical dotted line represents the | logFC | > 0.5 threshold line; the red and blue dots represent significantly up-regulated and down-regulated DEGs and DMGs, respectively; and the black dots represent the non-differential expression genes. Bidirectional hierarchical clustering heatmaps for differentially expressed genes (c) and differentially expressed methylation regions (d). Black represents asthmatic samples and white represents healthy controls. FDR, false discovery rate; FC, fold change; DEGs, differentially expressed genes; DMGs, differentially methylated genes
Fig. 2Comparison of DMGs and DEGs in a set of venn diagrams (a). Distribution map for differentially expressed genes with DNA methylation changes (b). The horizontal axis represents the degree of significant methylation difference, and the vertical axis represents the degree of gene expression difference. Red dots represent genes with opposite degrees of expression and methylation levels. DEGs, differentially expressed genes; DMGs, differentially methylated genes
GO BPs and KEGG pathways significantly related to 130 differential genes
| Category | Term | Count | PValue |
|---|---|---|---|
| Biology process | GO:0006968 ~ cellular defense response | 5 | 1.06E−03 |
| GO:0006952 ~ defense response | 13 | 1.90E−03 | |
| GO:0055114 ~ oxidation reduction | 12 | 7.47E−03 | |
| GO:0051494 ~ negative regulation of cytoskeleton organization | 4 | 7.79E−03 | |
| GO:0002696 ~ positive regulation of leukocyte activation | 5 | 7.86E−03 | |
| GO:0050867 ~ positive regulation of cell activation | 5 | 9.21E−03 | |
| GO:0002703 ~ regulation of leukocyte mediated immunity | 4 | 1.03E−02 | |
| GO:0019835 ~ cytolysis | 3 | 1.04E−02 | |
| GO:0051129 ~ negative regulation of cellular component organization | 5 | 2.10E−02 | |
| GO:0006922 ~ cleavage of lamin | 2 | 2.20E−02 | |
| GO:0006923 ~ cleavage of cytoskeletal proteins during apoptosis | 2 | 2.20E−02 | |
| GO:0010639 ~ negative regulation of organelle organization | 4 | 2.28E−02 | |
| GO:0006865 ~ amino acid transport | 4 | 2.90E−02 | |
| GO:0042330 ~ taxis | 5 | 3.08E−02 | |
| GO:0006935 ~ chemotaxis | 5 | 3.08E−02 | |
| GO:0016310 ~ phosphorylation | 12 | 3.39E−02 | |
| GO:0002694 ~ regulation of leukocyte activation | 5 | 3.46E−02 | |
| GO:0051251 ~ positive regulation of lymphocyte activation | 4 | 3.51E−02 | |
| GO:0001562 ~ response to protozoan | 2 | 3.64E−02 | |
| GO:0043242 ~ negative regulation of protein complex disassembly | 3 | 3.68E−02 | |
| GO:0002697 ~ regulation of immune effector process | 4 | 3.88E−02 | |
| GO:0050865 ~ regulation of cell activation | 5 | 4.07E−02 | |
| GO:0001817 ~ regulation of cytokine production | 5 | 4.52E−02 | |
| GO:0006690 ~ icosanoid metabolic process | 3 | 4.72E−02 | |
| KEGG pathway | hsa04650:Natural killer cell mediated cytotoxicity | 5 | 3.59E−03 |
| hsa00280:Valine, leucine and isoleucine degradation | 3 | 6.42E−03 | |
| hsa00140:Steroid hormone biosynthesis | 3 | 6.95E−03 | |
| hsa04080:Neuroactive ligand-receptor interaction | 6 | 9.17E−03 | |
| hsa00590:Arachidonic acid metabolism | 3 | 9.75E−03 | |
| hsa04514:Cell adhesion molecules (CAMs) | 4 | 1.28E−02 | |
| hsa04612:Antigen processing and presentation | 3 | 1.84E−02 | |
| hsa00240:Pyrimidine metabolism | 3 | 2.26E−02 | |
| hsa00230:Purine metabolism | 3 | 4.26E−02 | |
| hsa04060:Cytokine-cytokine receptor interaction | 4 | 4.53E−02 |
BPs biology processes, KEGG Kyoto Encyclopedia of Genes and Genomes
Fig. 3The protein–protein interaction network of genes with opposite directions of expression and methylation levels. The blue triangle represents hypermethylated downregulated genes, the red triangle represents hypomethylated upregulated genes
GO BPs and KEGG signal pathways enrichment analysis in interaction network
| Category | Term | Count | PValue |
|---|---|---|---|
| Biology process | GO:0006968 ~ cellular defense response | 5 | 9.48E−04 |
| GO:0006952 ~ defense response | 13 | 1.46E−03 | |
| GO:0055114 ~ oxidation reduction | 12 | 5.95E−03 | |
| GO:0002696 ~ positive regulation of leukocyte activation | 5 | 7.07E−03 | |
| GO:0050867 ~ positive regulation of cell activation | 5 | 8.29E−03 | |
| GO:0051129 ~ negative regulation of cellular component organization | 5 | 1.90E−02 | |
| GO:0016310 ~ phosphorylation | 12 | 2.78E−02 | |
| GO:0042330 ~ taxis | 5 | 2.80E−02 | |
| GO:0006935 ~ chemotaxis | 5 | 2.80E−02 | |
| GO:0002694 ~ regulation of leukocyte activation | 5 | 3.14E−02 | |
| GO:0050865 ~ regulation of cell activation | 5 | 3.71E−02 | |
| GO:0001817 ~ regulation of cytokine production | 5 | 4.11E−02 | |
| GO:0006796 ~ phosphate metabolic process | 13 | 4.51E−02 | |
| GO:0006793 ~ phosphorus metabolic process | 13 | 4.51E−02 | |
| GO:0006468 ~ protein amino acid phosphorylation | 10 | 4.96E−02 | |
| GO:0009617 ~ response to bacterium | 5 | 5.00E−02 | |
| KEGG pathway | hsa04650:Natural killer cell mediated cytotoxicity | 5 | 3.35E−03 |
| hsa00280:Valine, leucine and isoleucine degradation | 3 | 6.19E−03 | |
| hsa00140:Steroid hormone biosynthesis | 3 | 6.69E−03 | |
| hsa04080:Neuroactive ligand-receptor interaction | 6 | 8.55E−03 | |
| hsa00590:Arachidonic acid metabolism | 3 | 9.40E−03 | |
| hsa04612:Antigen processing and presentation | 3 | 1.78E−02 | |
| hsa00240:Pyrimidine metabolism | 3 | 2.19E−02 | |
| hsa04514:Cell adhesion molecules (CAMs) | 3 | 3.46E−02 | |
| hsa00230:Purine metabolism | 3 | 4.16E−02 | |
| hsa04060:Cytokine-cytokine receptor interaction | 4 | 4.39E−02 |
BPs biology processes, KEGG Kyoto Encyclopedia of Genes and Genomes
Fig. 4MiRNA regulatory network. The blue triangle represents hypermethylated downregulated genes, the red triangle represents hypomethylated upregulated genes, and the yellow circle indicates miRNAs directly related to asthma
The KEGG pathways significantly related to target genes in miRNA regulatory network
| Term | Count | PValue | Genes |
|---|---|---|---|
| hsa00280:Valine, leucine and isoleucine degradation | 3 | 2.40E−03 | HADH, PCCA, ACAA1 |
| hsa00240:Pyrimidine metabolism | 3 | 9.54E−03 | ENTPD5, POLR3A, ENTPD1 |
| hsa04514:Cell adhesion molecules (CAMs) | 3 | 1.64E−02 | NCAM1, CDH1, SPN |
| hsa04080:Neuroactive ligand-receptor interaction | 4 | 1.65E−02 | S1PR2, S1PR3, S1PR1, S1PR5 |
| hsa05340:Primary immunodeficiency | 2 | 1.76E−02 | IL2RG, RFXANK |
| hsa00071:Fatty acid metabolism | 2 | 1.99E−02 | HADH, ACAA1 |
| hsa00230:Purine metabolism | 3 | 2.05E−02 | ENTPD5, POLR3A, ENTPD1 |
| hsa04623:Cytosolic DNA-sensing pathway | 2 | 2.63E−02 | POLR3A, CCL4 |
| hsa04060:Cytokine-cytokine receptor interaction | 3 | 4.27E−02 | CCL2, IL2RG, CCL4 |
KEGG Kyoto Encyclopedia of Genes and Genomes
Fig. 5Genes directly related to asthma and KEGG pathways. The blue triangle represents hypermethylated downregulated genes, the red triangle represents hypomethylated up-regulated genes, the yellow circle represents miRNAs directly related to asthma, and the yellow square represents KEGG signal pathways directly related to asthma. KEGG, Kyoto Encyclopedia of Genes and Genomes